- Bristol Myers Squibb (Cambridge, MA)
- …and regulatory interactions as needed **Skills/Knowledge Required** + 7+ years of late stage clinical biomarker experience in industry (biotech/pharma) ... Senior Scientific Director Translational Medicine (TM), the Director will be part of the late ...be responsible for setting strategy for translational activities including clinical biomarker activities to support drug development… more
- Organon & Co. (Boston, MA)
- …can be 100% remote in the US + There are **2 openings** The Director , Clinical Pharmacology Lead will be responsible for contributing and/or devising the ... while ensuring the scientific and data integrity, rigor and quality thereof. The director may represent the Clinical Pharmacology function in asset development… more
- Bristol Myers Squibb (Cambridge, MA)
- …both at work and in their personal lives. Read more: careers.bms.com/working-with-us . ** Director , Early Clinical Development (MD) - Hematology & Cell Therapy ... assets and sits at the interface between discovery and translational science and clinical drug development. The Director , Early Clinical Development role… more
- Merck (Boston, MA)
- …+ Interface directly with scientists and physicians in discovery sciences, early-stage clinical development, and late -stage clinical development, as well ... a subject matter expert within our Company, collaborating with project teams, biomarker leads, clinical operations, and regulatory affairs on the implementation… more
- Sumitomo Pharma (Boston, MA)
- …We are currently seeking a versatile and experienced Senior Manager - Associate Director level scientist with strengths in clinical pharmacology, and a working ... of drug metabolism and bioanalytic chemistry. This position will report to Senior Director of Clinical Pharmacology and Drug Metabolism. S/he will work across… more
- Bristol Myers Squibb (Cambridge, MA)
- …colleagues in Translational Medicine, Informatics and Predictive Sciences and Early Clinical Development to generate biomarker and patient enrichment hypotheses ... We are a fully integrated drug discovery through translational and early clinical development organization which exploits state-of-the-art in vitro, in vivo and… more